NovaGo Therapeutics

📍 Schlieren, Switzerland🗓 Founded 2015👥 7 employees💰 Last funded Mar 2019
Biotechnology🌐 novagotherapeutics.com
Website LinkedIn
NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications. NovaGo’s proprietary antibodies block the function of Nogo-A, one of the most potent and well-studied vascular and nerve growth inhibitors.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in NovaGo Therapeutics?
NovaGo Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did NovaGo Therapeutics last raise funding?
The most recent investment in NovaGo Therapeutics recorded on gritt.io was in March 2019.
When was NovaGo Therapeutics founded?
NovaGo Therapeutics was founded in 2015.
What industry is NovaGo Therapeutics in?
NovaGo Therapeutics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is NovaGo Therapeutics based?
NovaGo Therapeutics is headquartered in Schlieren, Switzerland.